NEW YORK, Aug. 19 (GenomeWeb News) -Harvard Biosciences has completed two management changes, naming Susan Luscinski Chief Operating Officer and hiring Bryce Chicoyne as its new Chief Financial officer, the company said late Wednesday.
Luscinski, who has been at the company for the past 20 years, most recently served as CFO. In her new role, Luscinski will now focus on business planning and operations, the company said.
Luscinski "is being promoted because we think she can help us improve operating margin - one of our key operating metrics," David Green, president of Harvard Bioscience, said in an email to GenomeWeb News.
Chicoyne, the new CFO, comes to Harvard Bioscience from Apogent Technologies, where he was the director of financial reporting. His experience includes SEC compliance, financial management, mergers and acquisitions, and debt and equity financing.
These changes follow on the heels of the company's announcement of flat revenues and dwindling earnings in the second quarter, which it attributed to the Genomic Solutions product line.
The company announced in the second-quarter earnings call that it was cutting 36 employees from the Genomic Solutions unit and shuttering the Genomic Solutions San Carlos, Calif. production site.